Upgrade to SI Premium - Free Trial

RBC Capital Starts Charles River Labs (CRL) at Outperform, $215 PT

April 13, 2026 5:12 PM
RBC Capital analyst Ryan Halsted initiates coverage on Charles River Labs (NYSE: CRL) with a Outperform rating and a price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage